Reduced-dose WBRT combined with SRS for 1-4 brain metastases aiming at minimizing neurocognitive function deterioration without compromising brain tumor control.

Clin Transl Radiat Oncol · 2022 · PMC9529504 · PMID 36199814

Europe PMC DOI

hedged sentence

0.0770

closest p · 1.5× alpha

0.0770

boldest claim

The sentences

showed a trendp = 0.077so close (0.05 < p ≤ 0.1)

Patients with EGFR- or ALK-positive lung-adenocarcinoma showed a trend of better OS compared to those with other histopathologies (MST: 37.2 months vs. 14.6 months, p = 0.077) ( Table A2 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.